Analysis
Joshua Kushner, the venture investor behind Thrive Capital, has agreed to buy the Los Angeles Lakers for $12.5 billion, according to Fortune, a price that puts the deal among the largest professional sports transactions in history and reflects how far sports-franchise valuations have run in the past several years as institutional and billionaire capital competes for a fixed supply of marquee teams.
Thrive Capital, which Kushner founded in 2009 and has grown into one of the most consequential AI-era venture firms, has been a direct investor in OpenAI and just this week closed a separate $2 billion raise for Thrive Holdings, its OpenAI-backed rollup vehicle that buys and rebuilds services businesses with AI. That's a notably broad span of capital deployment in a single week -- venture bets on frontier AI labs, a private-equity-style AI rollup strategy, and now a $12.5 billion consumer sports asset, all from the same investor and firm ecosystem.
The Lakers purchase sits in a wave of mega-valuations for marquee US sports franchises, following record sales of teams like the Boston Celtics and Washington Commanders in recent years, as sports ownership has increasingly attracted the same class of tech and finance billionaires who once concentrated their capital purely in startups and public equities. Unlike a venture bet, a team like the Lakers offers a scarce, non-replicable asset with durable media rights value -- a different risk profile entirely from the AI investments Kushner is simultaneously making, but one that benefits from the same pool of capital looking for inflation-resistant, trophy-asset diversification.
“Both men are operating at a scale where scrutiny is guaranteed regardless of the decision, which changes the calculus around big, public moves.”
Fortune's framing draws an explicit parallel to OpenAI CEO Sam Altman, noting Altman has said he 'doesn't care' what others think of his decisions -- a comparison that fits Kushner's own pattern of moving decisively into concentrated, highly visible bets (AI labs, an AI rollup strategy, now an NBA franchise) without much public deliberation. Both men are operating at a scale where scrutiny is guaranteed regardless of the decision, which changes the calculus around big, public moves.
What the price obscures is leverage: sports-franchise deals at this size are rarely all-cash, and the debt structure behind a $12.5 billion purchase -- along with any co-investors Kushner brings in -- will matter more to whether this ages well than the headline number itself.
The comparable set for sports-franchise pricing has moved fast. The Boston Celtics sold for a reported price in the low billions just a couple of years ago; the Lakers deal, at $12.5 billion, reflects both the scarcity premium of one of the NBA's most globally recognized brands and the same broader asset-price inflation showing up across AI valuations, real estate and now trophy sports franchises simultaneously -- all markets where a relatively small number of billionaires and sovereign-adjacent funds are competing for a fixed or shrinking supply of premium assets. That's a different dynamic than a venture round, where new company formation can in theory expand supply; there is only one Lakers.
For Thrive Capital specifically, the purchase raises a governance question LPs should ask directly: is this personal capital, a separate vehicle, or does it touch fund resources in any way. Multi-strategy GPs increasingly blur these lines as their personal net worth scales alongside fund AUM, and sports-team ownership -- unlike a venture investment -- offers no clear path to LP co-investment or eventual distribution back to a fund's limited partners.
Watch for the ownership group's full composition and whether other Thrive-adjacent investors take minority stakes alongside Kushner.